JP Patent
JP4923144B2 — スルホアルキルエーテルシクロデキストリン組成物
Assigned to サイデックス・ファーマシューティカルズ・インコーポレイテッド · Expires 2012-04-25 · 14y expired
What this patent protects
Patent listed against Zulresso.
Drugs covered by this patent
- Zulresso (BREXANOLONE) · Sage Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.